A study was done to investigate possible late central nervous system (CNS) complications of latent measles infection in hamsters. Signs of CNS disease, consisting of myoclonus and paralysis, occurred in some weanling hamsters inoculated intraperitoneally at 3 or 9 days of age with antithymocyte serum (ATS) and measles virus, but no late complications in adult life attributable to measles virus were seen. A single series of ATS injections plus an injection of measles virus resulted in sustained antibody formation postulated due to establishment of a latent viral infection, whereas similar treatment with normal rabbit serum plus virus caused no or minimal antibody response. The majority of hamsters receiving ATS as newborns and ATS plus virus as weanlings also did not produce antibody. This differential effect of ATS may be due to combined elimination of suppressor and helper cells in the latter ATS-treated group and of suppressor cells only in the former ATS-treated group. Cellular immunity could not be evaluated since lymphocytes from inoculated and uninoculated hamsters released equal and variable amounts of 5'Cr for both infected and noninfected labeled, allogeneic hamster target cells.
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The immunological implications in the pathogenesis of subacute sclerosing panencephalitis (SSPE) induced by latent measles virus infection of the central nervous system (CNS) are not clear at present. Antibody titers to measles virus in serum and cerebrospinal fluid at the time of recognized CNS disease are elevated by all criteria tested. There is less unanimity in reports on cellular immunity (14) . Some studies indicate a reduced cellular response (8, 11, 12, 17, 21) ; others indicate a normal response (13, 16, 19, 20) . We (9) , among others (6, 7) , have attempted to develop an animal model to permit study of the immunological factors operative in the disease and in the viral infection. Antithymocyte serum (ATS) treatment of newborn hamsters rendered them susceptible to intraperitoneal (i.p.) injection of an SSPE strain of measles virus (Lec), a route of injection to which the untreated hamster is resistant. Such ATS-treated animals developed delayed overt signs of CNS involvement 3 weeks after virus inoculation. Only a small number ofthe treated hamsters survived, and with time these developed high titers of circulating antibody to measles virus, suggesting development ofa chronic, latent viral infection. Virus was isolated from the ATS-treated hamsters with CNS disease,
but not from the survivors tested.
Because of the suggested implication of latent measles virus infection resulting from childhood measles in the etiology of multiple sclerosis, the present investigation was initiated as a long-term study to determine whether treated hamsters with continuing elevated antibody titers would develop CNS disease later in life and to test cellular, as well as humoral, immune responses to measles virus in these hamsters.
MATERIALS AND METHODS Animals. Golden Syrian hamsters bred in our facility were inoculated i.p. at 24 h of age (experiment 1) or at 1 week of age (experiment 2) on three consecutive days with 0.1 ml of ATS or with normal rabbit serum (NRS). On day 3, 0. A known positive hamster hyperimmune serum was included in each run, and, with a 5% specific release as the end point (10), the titer of this serum did not vary more than ± 1 doubling dilution, which is considered within the error of a doubling dilution test.
Medium. Continuous cell lines were grown in Eagle minimum essential medium with added 10% fetal bovine serum, glutamine, and antibiotics. Primary cultures were grown in Eagle fortified minimal essential medium with 20% added fetal bovine serum, glutamine, and antibiotics.
Lymphocyte cytotoxicity measured by 51Cr release. Lymphocytes from peripheral blood in seven experiments and from spleen in three experiments were isolated by centrifugation on HypaqueFicoll gradients (1.077 g/ml) as described by Boyum (4) . They were washed three times with phosphatebuffered saline (pH 7.2) containing 10% fetal bovine serum and were then suspended to give a lymphocyte-to-target cell ratio of 50 for peripheral blood lymphocytes and 100 and 200 for spleen lymphocytes in a volume of 0.1 ml. The BHK 0853 cell line chronically infected with Lec virus as described was used as target cells. The first two runs were done with monolayer cultures for target cells, 104 cells plated per well in 96-well microplates. After incubation for 48 h, the monolayer was labeled and washed in situ. The rest of the runs were done with cells in suspension, 104 cells per test. The infected and uninfected cells were labeled with 5'Cr as described for serum cytotoxicity. Target cells, infected and noninfected, plus lymphocytes or target cells plus medium only were incubated for 14 to 16 h in 5% CO2-95% air at 36°C. After centrifugation, 50 ul of the supernatant fluid was counted in a Beckman gamma 300 spectrometer or in a Nuclear-Chicago scintillation counter, with Readysolve VI (Beckman) as the fluor.
Calculations were as follows: % specific release = cpm in supernatant fluid of (cellsi + lymphocytes) - The specific release by lymphocy,Aes from the virus-inoculated hamsters was then compared with that released by lymphocytes from hamsters inoculated with NB homogenate. Significance was considered if the former release exceeded the latter by 2 10%.
All tests were done in duplicate and, where lymphoid cells were sufficient, in triplicate. Six to nine animals were tested in each experiment, with two to four animals from each Lec-inoculated group and one to three animals from the controls groups for a total of 62 hamsters.
Histopathology. Brain tissues and other organs from selected hamsters were fixed in 10% buffered Formalin, sectioned, and stained with hematoxylin and eosin for microscopic study.
RESULTS
Experiment 1: Newborn hamsters inoculated with Lec virus. Part i. In both of the groups of NRS-and ATS-treated animals, 15 to 24% of the hamsters died or were missing within the first 8 days (Table 1) , presumably cannibalized by the mother. These losses were attributed to the trauma of the inoculations and/or the toxicity of the inocula. Prior to weaning, there were three more losses in the ATS-plus-NB group and two in the NRS-plusLec virus group. At about 2 weeks of age and continuing for the rest of the month, 13 ofthe 26 remaining hamsters in the ATS-plus-Lec virus group began to show signs of irritability, hyperactivity, or paralysis in the hind quarters, and/ or myoclonic jerking. Once signs were obvious, the animals were autopsied, and their brains were removed and frozen for later viral isolation. Of the remaining animals in this group, seven were found dead and six were missing at daily inspection, presumably cannibalized by the female, a not unusual occurrence with female hamsters, particularly if the infant animals are ill. The lone survivor in the group lived for the 2-year duration of the experiment. It was bled periodically during this period. Its neutralizing antibody titer rose to 1:256 and remained elevated. The animal never showed obvious signs of CNS disease.
Virus was isolated from brain and/or spleen homogenates of 12 of the 13 hamsters dying with overt signs of CNS disease. Cytopathic effects were seen in Vero cells at the first passage, and FA staining with specific antimeasles conjugate confirmed that the infecting agent was measles virus.
Part ii. The surviving animals in the ATSplus-NB group and in the NRS-plus-Lec virus group were bled at 27 days of age, and each group was divided into two groups. They were inoculated i.p. with 0.25 ml of ATS or NRS for 3 consecutive days, and on day 3 with either 0.3 ml of NB or 0.3 ml of Lec brain homogenate, followed by 3 more days of ATS or NRS injections (see Table 2 ).
The hamsters were checked periodically for appearance of neutralizing antibody. Of the animals receiving NRS plus Lec virus as newborns and ATS or NRS plus Lec virus as weanlings, 80% had antibody at 2 weeks and 100% had antibody at 1.5 and 2.5 months postinoculation. None of the hamsters receiving ATS plus NB as newborns and ATS plus Lec virus as weanlings had antibody at 2 weeks, and only 18 and 25% had antibody at 1.5 and 2.5 months, respectively ( (Table 4) . The majority of ATS-treated hamsters injected with measles virus formed antibody, whereas those treated with NRS did not. Cytotoxic antibody titers checked on three of the bleedings followed the same pattern as the neutralizing antibody titers ( Table 5 ). Most of the cytotoxicity titers did not differ by more than a doubling dilution from the neutralizing titer (Fig. 1) a Hamsters were inoculated i.p. at 1 week of age with either ATS or NRS for 3 days; on day 3 they received Lec virus i.p., followed by three more serum injections.
b Months postinoculation. Autopsy specimens. Lymphocyte cytotoxicity. Sixty-two hamsters at 4 to 6 months of age were studied for lymphocyte cytotoxicity, 47 of which were inoculated with either NRS or ATS and Lec virus; 15 were inoculated with either ATS or NRS and NB. Thirty-two were from experiment 1, and 30 were from experiment 2. In 9 of the 10 experiments done, the lymphocytes from the NRS-or ATS-treated hamsters inoculated with Lec virus or with NB showed a variable and approximately equal degree of cytotoxicity to the infected target cells as the uninfected target cells (Table 6 ). In one of the 10 experiments, six of eight hamsters inoculated with Lec virus showed a significant release of 5'Cr from infected target cells (Table 7) , as compared with that released from noninfected cells and that released by lymphocytes from hamsters given NB. The cytotoxicity was blocked with autologous serum. The lymphocytes from this same group of hamsters, checked 2.5 months later, no longer caused significant increase in 5"Cr release as compared with controls. There was no correlation between presence and absence of lymphocytotoxicity and antibody titers in these hamsters.
DISCUSSION
As in our previous study (9) , ATS-treated newborn hamsters inoculated with Lec virus VOL. 16, 1977 on November 2, 2017 by guest http://iai.asm.org/ Downloaded from developed signs of CNS disease, and virus was isolated from the brain. A week's difference in age at the time of ATS treatment and virus inoculation made a marked difference in occurrence of CNS disease (Tables 1 and 3 ). Chronic encephalitis due to measles virus in another hamster model was also dependent upon ag, of inoculation (6) . The theory has been advanced that the nature of complications from measles (SSPE versus multiple sclerosis) is correlated with age at time of infection (1). These investigators reported that multiple sclerosis patients often give a history of measles at an older age than individuals not so afflicted (5 to 9 years of At the time of onset of overt signs of CNS disease in the ATS-treated hamsters, antibody was absent or present in low titer (9) . The serum titer at autopsy of the animal that survived for 1 month with chronic progressive signs of CNS involvement in experiment 2 was only 1:8. At the time clinical symptoms of SSPE are recognized in children, their antibody titers are high. The antibody titer at the time of establishment of the latent infection in the CNS, before overt symptoms, is unknown. Since SSPE is a rare disease in the United States, a prospective study is not feasible.
Inoculation of virus into 1-week-old hamsters in the absence of ATS treatment did not induce an antibody response in the majority of the inoculated animals (experiment 2, Table 4 ), nor did it cause any clinical signs of CNS infection (Table 3 ). These data suggest that the immature animal, although incapable of producing significant antibody response at that age, was still able to prevent a latent viral infection and spread of the virus to the CNS, due presumably to cellular immune mechanisms. The fact that most of the animals never did form antibody detectable at a 1:8 dilution is strong support for their ability to eliminate the virus, since a latent infection would supply a continued source of antigen for antibody stimulation in the immunologically mature adult. On the other hand, the majority of ATS-treated hamsters that survived developed antibody titers, some of which remained elevated; others, while declining, remained at detectable levels throughout the months of the experiment (Table 4). It would appear that, although a latent infection was probably established in some of these animals, entry to the brain was prevented.
An added factor in the production of antibody in ATS-but not in NRS-treated hamsters may be the inactivation of suppressor cells by ATS. It has been reported that ATS or antilymphocyte serum treatment of mice results in an enhanced antibody response to pneumococcal polysaccharide, an effect attributed to inactivation of suppressor cells (3) . Regardless of the mechanism of action of ATS in the present study, the lack of antibody response in NRStreated hamsters, coupled with lack of invasion of the CNS, suggests no significant role for serum-neutralizing antibody for this model in protection against disease of the CNS by measles virus injected parenterally. Cytotoxic antibody titers closely followed those of neutralizing-antibody titers in the two serum-treated groups inoculated with Lec virus (Table 5 and Fig. 1 ). All but one of the ATS-treated animals developed cytotoxic antibody, whereas only four of the NRS-treated hamsters formed such antibody. Cytotoxic antibody at the levels produced apparently does not promote late CNS disease in this model, since none of the ATStreated group developed overt signs of disease in later life.
Approximately 30% of the NRS-treated hamsters inoculated with Lec virus at 72 h responded with antibody production when tested at 27 days (experiment 1, Table 2 ). All eventually responded to a second injection of virus, whether in combination with NRS or ATS. ATS treatment did not affect the anamnestic response, since those responding to the first injection of virus as newborns were those with highest titers (1:128 to 1:256) at 2 weeks after the second injection of virus.
It is of interest to compare the antibody response of the group in experiment 1 receiving ATS plus NB as newborns and ATS plus Lec at weaning (Table 2 ) with those receiving only ATS plus Lec at 1 week of age (Table 4) . There was a definite reduction in the number of responders with the former treatment as compared with the latter. Only two animals had a titer at 9 months, one of which was elevated (titer of 1:256). This differential effect ofATS on antibody formation may relate to the stage of maturation of the affected cells at time of treatment. With the former treatment, more heterogeneity and/or immaturity of affected cells may be expected since the population would be just recovering from the first series of ATS injections when the second series was started. Also, there is probably a time sequence in development of suppressor and helper T-cells during the neonatal period, with suppressor cells developing first (G. M. Troup and R. E. Anderson, Fed. Proc., p. 734, no. 2911, 1976) and helper cells later. In such a case, the first ATS
